StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience cash

Cash and short-term investments held at the end of each period.

Pure Bioscience's cash was $569.00K at Jul 31, 2026. For fiscal 2026 it was $569.00K, up 70.4% from the year before. Over ten years it grew -19.8% a year on average. The highest annual figure on record is $5.19M in fiscal 2016.

Annual cash

PeriodPeriod endValueChange
FY2026Jul 31, 2026$569.00K+70.4%
FY2025Jul 31, 2025$334.00K-4.3%
FY2024Jul 31, 2024$349.00K-68.1%
FY2023Jul 31, 2023$1.10M-67.7%
FY2022Jul 31, 2022$3.39M+41.9%
FY2021Jul 31, 2021$2.39M-37.7%
FY2020Jul 31, 2020$3.84M+864.6%
FY2019Jul 31, 2019$398.00K-53.2%
FY2018Jul 31, 2018$851.00K-50.4%
FY2017Jul 31, 2017$1.72M-67.0%
FY2016Jul 31, 2016$5.19M+293.2%
FY2015Jul 31, 2015$1.32M+1436.0%
FY2014Jul 31, 2014$86.00K0.0%
FY2013Jul 31, 2013$86.00K-90.2%
FY2012Jul 31, 2012$877.00K-51.1%
FY2011Jul 31, 2011$1.79M-18.2%
FY2010Jul 31, 2010$2.19M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 2026$569.00K+70.4%
Q3 FY2026CQ1 2026Apr 30, 2026$983.00K+82.0%
Q2 FY2026CQ4 2025Jan 31, 2026$198.00K-2.0%
Q1 FY2026CQ3 2025Oct 31, 2025$434.00K+25.4%
Q4 FY2025CQ2 2025Jul 31, 2025$334.00K-4.3%
Q3 FY2025CQ1 2025Apr 30, 2025$540.00K+22.2%
Q2 FY2025CQ4 2024Jan 31, 2025$202.00K-63.7%
Q1 FY2025CQ3 2024Oct 31, 2024$346.00K-76.0%
Q4 FY2024CQ2 2024Jul 31, 2024$349.00K-68.1%
Q3 FY2024CQ1 2024Apr 30, 2024$442.00K-43.4%
Q2 FY2024CQ4 2023Jan 31, 2024$557.00K-62.5%
Q1 FY2024CQ3 2023Oct 31, 2023$1.44M-41.3%
Q4 FY2023CQ2 2023Jul 31, 2023$1.10M-67.7%
Q3 FY2023CQ1 2023Apr 30, 2023$781.00K+52.8%
Q2 FY2023CQ4 2022Jan 31, 2023$1.49M+31.3%
Q1 FY2023CQ3 2022Oct 31, 2022$2.45M+39.3%
Q4 FY2022CQ2 2022Jul 31, 2022$3.39M+41.9%
Q3 FY2022CQ1 2022Apr 30, 2022$511.00K-81.9%
Q2 FY2022CQ4 2021Jan 31, 2022$1.13M-61.4%
Q1 FY2022CQ3 2021Oct 31, 2021$1.76M-49.2%
Q4 FY2021CQ2 2021Jul 31, 2021$2.39M-37.7%
Q3 FY2021CQ1 2021Apr 30, 2021$2.82M+39.4%
Q2 FY2021CQ4 2020Jan 31, 2021$2.93M+1089.8%
Q1 FY2021CQ3 2020Oct 31, 2020$3.47M+283.4%
Q4 FY2020CQ2 2020Jul 31, 2020$3.84M+864.6%
Q3 FY2020CQ1 2020Apr 30, 2020$2.02M+494.7%
Q2 FY2020CQ4 2019Jan 31, 2020$246.00K-26.6%
Q1 FY2020CQ3 2019Oct 31, 2019$904.00K+16.5%
Q4 FY2019CQ2 2019Jul 31, 2019$398.00K-53.2%
Q3 FY2019CQ1 2019Apr 30, 2019$340.00K-66.6%
Q2 FY2019CQ4 2018Jan 31, 2019$335.00K-84.3%
Q1 FY2019CQ3 2018Oct 31, 2018$776.00K-76.5%
Q4 FY2018CQ2 2018Jul 31, 2018$851.00K-50.4%
Q3 FY2018CQ1 2018Apr 30, 2018$1.02M-62.5%
Q2 FY2018CQ4 2017Jan 31, 2018$2.13M-45.3%
Q1 FY2018CQ3 2017Oct 31, 2017$3.30M-18.7%
Q4 FY2017CQ2 2017Jul 31, 2017$1.72M–
Q3 FY2017CQ1 2017Apr 30, 2017$2.71M–
Q2 FY2017CQ4 2016Jan 31, 2017$3.89M–
Q1 FY2017CQ3 2016Oct 31, 2016$4.06M–

More Pure Bioscience figures

See a number that looks wrong?